BR0214993A - Processo para redução de acne ou aperfeiçoamento de tÈnus de pele - Google Patents

Processo para redução de acne ou aperfeiçoamento de tÈnus de pele

Info

Publication number
BR0214993A
BR0214993A BR0214993-1A BR0214993A BR0214993A BR 0214993 A BR0214993 A BR 0214993A BR 0214993 A BR0214993 A BR 0214993A BR 0214993 A BR0214993 A BR 0214993A
Authority
BR
Brazil
Prior art keywords
acne
skin
reduction
improvement
skin tone
Prior art date
Application number
BR0214993-1A
Other languages
English (en)
Inventor
Laura Mcculloch
Rachel Grossman
Lynn Halas
Benjamin Wiegand
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/017,180 external-priority patent/US20020151527A1/en
Priority claimed from US10/012,627 external-priority patent/US20020146469A1/en
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of BR0214993A publication Critical patent/BR0214993A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0016—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the smell sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0022—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the tactile sense, e.g. vibrations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0077—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with application of chemical or pharmacological stimulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/04—Skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Acoustics & Sound (AREA)
  • Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PROCESSO PARA REDUçãO DE ACNE OU APERFEIçOAMENTO DE TÈNUS DE PELE". A presente invenção refere-se a processos para (1) redução de número e seriedade de lesões de acne sobre a pele de um mamífero; (2) melhora de inflamação de lesões de acne sobre a pele de um mamífero; (3) aperfeiçoamento de tónus de pele de um mamífero, (4) tratamento de distúrbios de pele; (5) tratamento de doenças de pele relacionadas com tensão; (6) redução de tensão e aperfeiçoamento de bem-estar emocional de um sofredor de acne; (7) redução de produção de glândula sebácea; e (8) aumento de condescendência da administração de produtos antiacne. O processo compreende a administração de um regime sensório em uma quantidade eficaz para regular descendentemente a atividade do eixo hipotálamopituitária-adrenal (HPA) em combinação com a administração de uma composição antiacne.
BR0214993-1A 2001-12-07 2002-12-04 Processo para redução de acne ou aperfeiçoamento de tÈnus de pele BR0214993A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/017,180 US20020151527A1 (en) 2000-12-20 2001-12-07 Method for reducing acne or improving skin tone
US10/012,627 US20020146469A1 (en) 2000-12-20 2001-12-07 Methods for reducing chronic stress in mammals
PCT/US2002/038747 WO2003049769A2 (en) 2001-12-07 2002-12-04 Method for reducing acne or improving skin tone

Publications (1)

Publication Number Publication Date
BR0214993A true BR0214993A (pt) 2004-12-07

Family

ID=26683806

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214993-1A BR0214993A (pt) 2001-12-07 2002-12-04 Processo para redução de acne ou aperfeiçoamento de tÈnus de pele

Country Status (9)

Country Link
EP (1) EP1474170A1 (pt)
JP (1) JP2005517649A (pt)
KR (1) KR20040063166A (pt)
CN (1) CN1615152A (pt)
AU (2) AU2002359599A1 (pt)
BR (1) BR0214993A (pt)
CA (1) CA2469000A1 (pt)
MX (1) MXPA04005499A (pt)
WO (1) WO2003049769A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332546A1 (en) * 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of stroke
KR20080006568A (ko) * 2005-03-30 2008-01-16 레반스 테라퓨틱스, 아이엔씨. 여드름 치료용 조성물 및 방법
JP5109383B2 (ja) * 2007-01-31 2012-12-26 大正製薬株式会社 アダパレン含有外用剤組成物
KR100861978B1 (ko) * 2007-03-22 2008-10-07 한국콜마 주식회사 아젤라산을 이용한 여드름 치료용 화장료 조성물 및 그 제조방법
JP5522819B2 (ja) * 2008-01-29 2014-06-18 株式会社マンダム 抗菌性組成物及び皮膚外用剤
CN102159216A (zh) * 2008-07-17 2011-08-17 G·莱维斯 用于痤疮治疗的方法和材料
WO2012153884A1 (ko) * 2011-05-12 2012-11-15 (주)아모레퍼시픽 안정성이 향상된 여드름 개선용 조성물
JP5840437B2 (ja) * 2011-09-30 2016-01-06 日本メナード化粧品株式会社 抗炎症剤
CN106420787B (zh) * 2016-08-26 2020-05-26 陈启红 一种痤疮膏及其制备方法
CA3106323A1 (en) * 2018-07-30 2020-02-06 Curology, Inc. Compositions and methods of treating acne and photoaging

Also Published As

Publication number Publication date
EP1474170A1 (en) 2004-11-10
KR20040063166A (ko) 2004-07-12
CN1615152A (zh) 2005-05-11
AU2008203320A1 (en) 2008-08-21
MXPA04005499A (es) 2005-04-19
JP2005517649A (ja) 2005-06-16
WO2003049769A2 (en) 2003-06-19
AU2002359599A1 (en) 2003-06-23
CA2469000A1 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
Kasyanju Carrero et al. Botulinum toxin type A for the treatment and prevention of hypertrophic scars and keloids: updated review
El-On et al. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study
DE69929361T2 (de) Botulinumtoxine zur verstärkung der wundheilung
BR0013555A (pt) composições incluindo modafinila para tratamento da desordem da hiperatividade com déficit de atenção e fadiga por esclerose múltipla
CA2549550A1 (en) Botulinum toxin therapy for skin disorders
BR0211062A (pt) Combinações para o tratamento de distúrbios inflamatórios
BR0214993A (pt) Processo para redução de acne ou aperfeiçoamento de tÈnus de pele
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
BR0009647A (pt) Docetaxel em combinação com rhumab her2 para o tratamento de cânceres
ATE266417T1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
Iraji et al. Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma
BRPI0313792B8 (pt) utilização de proteína de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
Kasapoğlu-Aksoy et al. Comparison of the efficacy of intramuscular botulinum toxin type-A injection into the pectoralis major and the teres major muscles and suprascapular nerve block for hemiplegic shoulder pain: a prospective, double-blind, randomized, controlled trial
BR0312696A (pt) Tratamento tópico de doenças da pele
BRPI0416934A (pt) método para reduzir a gravidade dos distúrbios das células plasmáticas ou para o tratamento dos distúrbios das células plamáticas, método para reduzir a dose de um agente citotóxico, e, método para reduzir a produção de il-6 ou de vegf pelos fibroblastos que se acham em contato com as células plasmáticas cancerosas
Karimkulovich et al. The use of Retinoids in the Approach to the Cosmetic Treatment of Acne.
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
WO2003057162A3 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
Brady et al. Valproate treatment of comorbid panic disorder and affective disorders in two alcoholic patients.
AU610587B2 (en) Treatment of aged skin with oral 13-cis-retinoic acid
Dogra et al. Comparative efficacy of 20% trichloroacetic acid and 50% glycolic acid peels in treatment of recalcitrant melasma
Miškulin et al. New Topical Treatment of Symptomatic Internal Haemorrhoids in a General Practice Setting
Rohdewald Pycnogenol, a plant extract for women's health
Scarci et al. In Vitro Evaluations for a New Topical Anti-Aging Formulation

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1888 DE 13/03/2007.